Navigation Links
Hanger Orthopedic Group, Inc. Reports $0.31 EPS for the Second Quarter 2009 and Raises Full Year EPS Guidance
Date:7/28/2009

differ materially from those expressed in, or implied by, these statements, including the Company's ability to enter into and derive benefits from managed care contracts, the demand for the Company's orthotic and prosthetic services and products and the other factors identified in the Company's periodic reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934. The Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

-tables to follow-

                               Hanger Orthopedic Group, Inc.
                 (Dollars in thousands, except share and per share amounts)
                                       (Unaudited)

                               Three Months Ended       Six Months Ended
                                    June 30,                June 30,
    Income Statement:           2009        2008        2009        2008
    Net sales                $193,523     $181,184    $362,670    $338,840
    Cost of goods sold
     - materials               58,848       55,275     109,897     101,997
    Personnel costs            65,748       61,544     129,807     121,884
    Other operating
     expenses                  40,963       38,689      75,416      70,903
    Depreciation and
     amortization               3,808        4,289       8,264       8,470
    Income from operations     24,156       21,387      39,286      35,586
    Interest expense            7,595        8,045      15,202      16,303
    Unrealized gain from
     interest rate swap           167            -         167           -
    Income before taxes        16,728       13,342      24,251      19,283
    Provision for
     income taxes               6,692        5,337       9,700       7,713
    Net income                 10,036 
'/>"/>
SOURCE Hanger Orthopedic Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Hanger Orthopedic Group, Inc. Announces Second Quarter 2009 Earnings Release Conference Call
2. Hanger Orthopedic Group, Inc. Receives Upgrade from Standard & Poors Rating Services
3. Hanger Orthopedic Group, Inc. Announces Two Acquisitions Totaling $5.3 Million of Annual Net Revenue
4. Hanger Orthopedic Group, Inc. Reports $0.14 EPS on 26.6% Increase in Net Income for the First Quarter 2009
5. Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call
6. Hanger Orthopedic Group, Inc. Reports $0.26 Pro Forma EPS on 8.6% Sales Growth for the Fourth Quarter 2008
7. Hanger Orthopedic Group Welcomes Vinit Asar as Chief Growth Officer
8. Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue
9. Hanger Orthopedic Group, Inc. Announces 2008 Year-End Earnings Release Conference Call
10. Parker College of Chiropractic Education Launches Recruiting Campaign for Career Changers and Potential Students
11. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
(Date:11/25/2009)... Evaluation and treatment clinics to re...odstock (Vocus) November 25, 2009 -- Centegra Heal...es and H1N1 vaccine shots at four Centegra Primary...ment of vaccine has arrived. The clinics are at CP...Henry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...Currently lie detection methods use heart activity... quite accurately for lie detection reports the on...n scientist Pankaj Pasricha at the University of T...own - literally. It has its own well-developed ner...
... The government of India has today assured that th...a) in the country // The government has set...se eye on the on the domestic poultry population a...ose watch on the situation. Extensive surveillance...
... A new study indicates that there maybe gender dif...cer and women who smoke and drink maybe at higher...r Anna L. Zisman, M.D. of Evanston Northwestern He...hol use are well-established risk factors for colo...
...tudy was conducted to investigate the association ... density (BMD), and cardiovascular risk factors. T...her bone mineral // density than the controls, and...diabetics have bone mass alterations and may have ...
...-mediated bone marrow injury is an early or predis...d persistent hematopoietic disease, according to r...r 23 in the journal Leukemia Research. My...s, clonal evolution and a tendency to progress on ...
...ers have been used widely in the treatment of hype...rugs in hypertension guidelines. Moreover, after m...ilure, treatment // with beta blockers prevents re...hypertension. A recent study, published in t...
Other Medicine News:Health News:Women More Prone To Risk of Colorectal Cancer from Tobacco 2Health News:Diabetic Type II Women Have Elevated Bone Density Mass 2Health News:Evidence against use of Beta blockers as first choice in the treatment of primary hypertension 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
(Date:11/24/2009)...Newswire-FirstCall/--QuestDiagnosticsIncorporated(...esting,informationandservices,announcedthatitissch...ConferenceinNewYorkCity.Thepresentationisscheduled...,, Duringtheconference,thecompanywillreaffirmit...tingincometoexceed18%ofrevenues,anddilutedearnings...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 1LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 3Accera Inc to Present at UBS Global Life Sciences Conference 57667 1Accera Inc to Present at UBS Global Life Sciences Conference 57667 2Ulcer Preventative May Raise Pneumonia Risks 57664 1Ulcer Preventative May Raise Pneumonia Risks 57664 2
...SINESS WIRE)--Jun 13, 2007 - EPIX,Pharmaceuticals,...m,its Phase 3 trial of PRX-00023, a novel long-act...ntation at the 47th Annual New,Clinical Drug Evalu... The meeting is sponsored by the National Institut...Psychopharmacology., The presentation highlighted ...
...-(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharm...he Tel,Aviv Stock Exchange Exchange, proceeds with...in addition to CF101, which is currently,in clinic...s. This,weekend Can-Fite will present at the EUALR...ivo study results showing effective,anti-inflammat...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
HemoCue 201 DM System, Glucose
Triage® C. difficile Panel
Bartels® C. Difficile Toxin A Antigen EIA with Controls
... Toxin A C. difficile Rapid Toxin A Test gives you...minutes. When it might be C. difficile, you can't ...nly a few tests a day or sends out its suspected C...C. difficile Rapid Toxin A Test will cut costs and...
Medicine Products: